EyePoint Pharmaceuticals (EYPT) Announces Board and Executive Appointments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
October 16, 2023 7:00 AM EDTÂ Stuart Duty appointed to EyePoints Board of Directors
 George Elston promoted to Executive Vice PresidentÂ
WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced the appointment of Stuart Duty to its Board of Directors and the promotion of George Elston to Executive Vice President.
We are excited to welcome Mr. Duty to our Board of... More
